(PDF) Clinical Responses and Prognostic Indicators of

Clinical Responses and Prognostic Indicators of Concurrent Chemoradiation for Non-Small Cell Lung Cancer

Cancer Research and Treatment - South Korea

doi 10.4143/crt.2011.43.1.32

Full Text

Abstract

Available in full text

Categories

Cancer Research

Date

March 31, 2011

Authors

Jin-Hyoung Kang

Young-Kyoun Kim

Publisher

Korean Cancer Association

Related search

Prognostic Impact of Missed Chemotherapy Doses During Chemoradiation Therapy for Non–Small Cell Lung Cancer

American Journal of Clinical Oncology: Cancer Clinical Trials

Cancer Research

English

Concurrent Chemoradiation in Elderly Patients With Limited-Stage Small Cell Lung Cancer

Journal of Thoracic Oncology

Respiratory Medicine

English

Prognostic Gene Signatures for Non-Small-Cell Lung Cancer

Proceedings of the National Academy of Sciences of the United States of America

Multidisciplinary

English

Quality-Of-Care Indicators for Non-Small Cell Lung Cancer

English

Prognostic Value of Neutrophil-To-Lymphocyte Ratio Following Chemoradiation Therapy for Stage III Non–small Cell Lung Cancer

International Journal of Radiation Oncology Biology Physics

Cancer Research

Nuclear Medicine

English

Prognostic Factors for Survival After Recurrence of Stage III Non-Small Cell Lung Cancer Treated With Definitive Chemoradiation Therapy

International Journal of Radiation Oncology Biology Physics

Cancer Research

Nuclear Medicine

English

Preoperative Concurrent Chemoradiotherapy for Stage IIIA Non-Small Cell Lung Cancer

Acta Oncologica

Nuclear Medicine

English

Prognostic Significance of CD276 in Non-Small Cell Lung Cancer

Open Medicine (Poland)

English

Clinical Outcomes in Non-Small-Cell Lung Cancer Patients Receiving Concurrent Metformin and Immune Checkpoint Inhibitors

Lung Cancer Management

English